Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA
Pharma
Regulatory tracker: Amgen, Lilly, Takeda and Nxera nab Japan nods
Here, we're tracking the regulatory progress of in-market products, including expansions into key geographies and new indications.
Fraiser Kansteiner
,
Eric Sagonowsky
,
Angus Liu
,
Zoey Becker
,
Kevin Dunleavy
Sep 24, 2024 5:51pm
FDA says it's taking steps to boost shortfall in inspections
Sep 20, 2024 8:35am
PhRMA calls for edits to 'overly simplistic' misinformation text
Sep 16, 2024 12:15pm
Senators target online drug ad influencers in draft legislation
Sep 13, 2024 7:20am
FDA slams AbbVie for misleading claims in Serena Williams ad
Sep 12, 2024 6:48am
FDA issues Form 483s to Japanese, Indian drugmakers
Sep 10, 2024 8:50am